Brian McKeon Appointed to NVA Board of Directors
ByAinvest
Monday, Aug 18, 2025 9:34 am ET1min read
ALKS--
McKeon's career spans over a decade at IDEXX, where he led the company's finance, strategic planning, and investor relations functions. He oversaw IDEXX's livestock, water, and human diagnostics businesses. Before IDEXX, McKeon held executive roles at Iron Mountain Incorporated and The Timberland Company. He is currently a member of the Board of Directors of Alkermes plc, a global biopharmaceutical company [1].
"We are thrilled to welcome Brian to our Board of Directors," said Ken Burdick, Executive Chairman of NVA. "His extensive experience in finance and strategic planning, along with his proven leadership in the veterinary and diagnostics industries, will be invaluable as we continue to grow and innovate in the veterinary care sector" [1].
McKeon's appointment comes at a critical time for NVA, which is a community of approximately 1,300+ premier locations across North America, including general practice veterinary hospitals, Ethos Veterinary Health, equine hospitals, and pet resorts [1]. His strategic expertise will be instrumental in guiding NVA's initiatives and enhancing its commitment to providing high-quality veterinary care.
References:
[1] https://www.prnewswire.com/news-releases/national-veterinary-associates-welcomes-brian-mckeon-to-board-of-directors-302532286.html
IDXX--
IRM--
National Veterinary Associates (NVA) has appointed Brian McKeon to its Board of Directors. McKeon brings expertise in finance and strategic planning from his previous roles at IDEXX Laboratories and Alkermes plc. He will guide NVA's strategic initiatives and enhance its commitment to providing high-quality veterinary care. NVA is a community of veterinary hospitals, specialty and emergency hospitals, equine hospitals, and pet resorts across North America.
National Veterinary Associates (NVA) has announced the appointment of Brian McKeon to its Board of Directors, effective immediately. McKeon brings extensive experience in finance and strategic planning, having previously served as Chief Financial Officer and Treasurer of IDEXX Laboratories, Inc., an S&P 500 company, and most recently as IDEXX's Executive Vice President and Special Advisor [1].McKeon's career spans over a decade at IDEXX, where he led the company's finance, strategic planning, and investor relations functions. He oversaw IDEXX's livestock, water, and human diagnostics businesses. Before IDEXX, McKeon held executive roles at Iron Mountain Incorporated and The Timberland Company. He is currently a member of the Board of Directors of Alkermes plc, a global biopharmaceutical company [1].
"We are thrilled to welcome Brian to our Board of Directors," said Ken Burdick, Executive Chairman of NVA. "His extensive experience in finance and strategic planning, along with his proven leadership in the veterinary and diagnostics industries, will be invaluable as we continue to grow and innovate in the veterinary care sector" [1].
McKeon's appointment comes at a critical time for NVA, which is a community of approximately 1,300+ premier locations across North America, including general practice veterinary hospitals, Ethos Veterinary Health, equine hospitals, and pet resorts [1]. His strategic expertise will be instrumental in guiding NVA's initiatives and enhancing its commitment to providing high-quality veterinary care.
References:
[1] https://www.prnewswire.com/news-releases/national-veterinary-associates-welcomes-brian-mckeon-to-board-of-directors-302532286.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet